{{Rsnum
|rsid=742614
|Gene=TPM3P2
|Chromosome=20
|position=33894826
|Orientation=plus
|GMAF=0.4334
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 26.5 | 44.2 | 29.2
| HCB | 14.6 | 55.5 | 29.9
| JPT | 9.7 | 49.6 | 40.7
| YRI | 10.9 | 48.3 | 40.8
| ASW | 7.0 | 40.4 | 52.6
| CHB | 14.6 | 55.5 | 29.9
| CHD | 13.8 | 45.9 | 40.4
| GIH | 25.7 | 51.5 | 22.8
| LWK | 7.3 | 43.6 | 49.1
| MEX | 37.9 | 44.8 | 17.2
| MKK | 5.1 | 47.4 | 47.4
| TSI | 17.6 | 45.1 | 37.3
| HapMapRevision=28
}}{{PMID Auto GWAS
  |PMID=23362303
  |Trait=Stearic acid (18:0) plasma levels
  |Title=Genome-wide association study identifies novel loci associated with concentrations of four plasma phospholipid fatty acids in the de novo lipogenesis pathway: results from the Cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE) consortium.
  |RiskAllele=A
  |Pval=3E-7
  |OR=.10
  |ORtxt=unit decrease
  |OA=1
}}

{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA}}